Goldman Sachs’s Champions Oncology CSBR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-23,129
| Closed | -$201K | – | 5160 |
|
2025
Q1 | $201K | Buy |
+23,129
| New | +$201K | ﹤0.01% | 4680 |
|
2024
Q4 | – | Sell |
-48,413
| Closed | -$236K | – | 5041 |
|
2024
Q3 | $236K | Sell |
48,413
-20,891
| -30% | -$102K | ﹤0.01% | 4433 |
|
2024
Q2 | $358K | Buy |
69,304
+3
| +0% | +$16 | ﹤0.01% | 4120 |
|
2024
Q1 | $340K | Buy |
+69,301
| New | +$340K | ﹤0.01% | 4148 |
|
2017
Q1 | – | Sell |
-50,072
| Closed | -$127K | – | 4421 |
|
2016
Q4 | $127K | Sell |
50,072
-16,230
| -24% | -$41.2K | ﹤0.01% | 4039 |
|
2016
Q3 | $111K | Buy |
+66,302
| New | +$111K | ﹤0.01% | 4154 |
|